MARISA SPEER: Open Payments
NPI 1376898544 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 32 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,465 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $155 |
| ABBVIE INC. | 5 | $114 |
| Regeneron Healthcare Solutions, Inc. | 3 | $92 |
| Amgen Inc. | 4 | $79 |
| LEO Pharma Inc. | 3 | $68 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| UCB, Inc. | 2 | $38 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
| GENZYME CORPORATION | 1 | $35 |
| Lilly USA, LLC | 1 | $28 |
Products named: OPZELURA, DUPIXENT, OTEZLA, RINVOQ, ADBRY, SKYRIZI, Zoryve, Bimzelx.
Industry payments across CA — which companies pay providers there.
